Briumvi®
What is Briumvi®?
Briumvi® (ublituximab-xiiy) is a monoclonal antibody approved for the treatment of relapsing forms of multiple sclerosis (MS) in adults. It is part of the anti-CD20 therapy class, designed to target and deplete B cells — key players in the immune system’s attack on the nervous system in MS.Briumvi® offers a convenient and effective option for patients needing B-cell depleting therapy, featuring a shorter infusion time to enhance both treatment efficiency and patient experience.
How does Briumvi® work?
In multiple sclerosis (MS), the body’s own immune system mistakenly attacks the myelin sheath — the protective covering around nerve cells in the brain and spinal cord.One type of immune cell involved in this process is called a B-cell, which carries a marker called CD20 that helps identify it.
When the myelin sheath gets damaged, the nerve cells can’t communicate properly, leading to problems with movement, speech, balance, vision, and even bowel function over time.
While Briumvi is not a cure for MS, it works by targeting the CD20 marker on B-cells, helping to destroy them before they can cause more damage. This helps to calm the immune system and slow down the progression of the disease.
How much does Briumvi® cost?
Briumvi® cost can vary depending on several factors including insurance status and insurance provider. Our team at Rocky Mountain MS Clinic are committed to lowering costs and improving access for our patients.
We work with virtually all leading commercial insurance providers in the greater Intermountain region, including Aetna, Anthem, Blue Cross Blue Shield, Cigna, DMBA, EMI Health, Humana, PEHP Health & Benefits, Select Health, as Tricare, as well as Medicaid and Medicare.
We’re here to make treatment more affordable and less stressful. Our team takes care of prior authorizations and benefits verification for you, and we’ll personally guide you through copay assistance and foundation support programs to help lower your out-of-pocket costs.
Why Patients Choose Rocky Mountain Infusion Center to Receive Their Briumvi® Infusion:
Clinical Excellence and Neurological Expertise
Our infusion center is proud to have a board-certified neurologist on-site, along with a team of BSN-prepared and Multiple Sclerosis-certified Registered Nurses, all committed to delivering the highest standard of care for our patients.
Lower Costs and Financial Assistance
We handle prior-authorization, benefits verification, and guide patients through copay assistance and foundation programs to reduce out-of-pocket costs. Additional financial help may be available if you qualify — just ask, and we’ll help you explore every option.
A Cigna report recently found that with a physician-owned infusion site, like RMMSC’s Infusion Center, patients see much lower out-of-pocket and overall costs than they would at a hospital outpatient infusion center.
Important Info
Multiple Sclerosis
Briumvi® (ublituximab-xiiy): Approved in December 2022
TG Therapeutics, Inc.